TGFB1 and chronic obstructive pulmonary disease: This inhibition of the non-canonical pathway is critical in COPD and asthma in which TGF-β activates epithelial cells that change their phenotype to mesenchymal cells (Willis and Borok, 2007; Hackett et al., 2009; Sohal et al., 2014).